₹5,000-crore R&D scheme for pharma, medtech soon

This development is significant as R&D accounts for only 7% of the total expenditure of Indian pharma industry, compared with over 35% in developed countries.

from mint - news https://ift.tt/XWShJI3
https://ift.tt/dpHBqhk